Risk Factors for Progression and Toxic Effects After Preoperative Stereotactic Radiosurgery for Patients With Resected Brain Metastases

Overview of attention for article published in JAMA Oncology, August 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 20 news outlets
blogs: 2 blogs

twitter: 53 X users

Readers on

mendeley: 34 Mendeley

So far, Altmetric has seen 20 news stories from 20 outlets.

Preoperative SRS Has Favorable Risk-Benefit Profile in Patients With Brain Metastases

Cancer Therapy Advisor, 12 Jul 2023

(HealthDay News) — Preoperative stereotactic radiosurgery (SRS) may be effective for patients with resected brain metastases…

Preop Stereotactic Radiosurgery May Aid Outcomes With Resected Brain Metastases

Drugs.com, 10 Jul 2023

By Lori Solomon HealthDay Reporter MONDAY, July 10, 2023 -- Preoperative stereotactic radiosurgery (SRS) may be effective for…

Preop Stereotactic Radiosurgery May Aid Outcomes With Resected Brain Metastases

CrossRoads Today abc25, 10 Jul 2023

MONDAY, July 10, 2023 (HealthDay News) -- Preoperative stereotactic radiosurgery (SRS) may be effective for patients with…

Preop Stereotactic Radiosurgery May Aid Outcomes With Resected Brain Metastases

WFMZ-TV 69, 10 Jul 2023

MONDAY, July 10, 2023 (HealthDay News) -- Preoperative stereotactic radiosurgery (SRS) may be effective for patients with…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 16 additional news stories.